114 related articles for article (PubMed ID: 2514188)
1. Interaction between cisplatin and mesna in mice.
Dorr RT; Lagel K
J Cancer Res Clin Oncol; 1989; 115(6):604-5. PubMed ID: 2514188
[TBL] [Abstract][Full Text] [Related]
2. Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin.
Wagner T; Kreft B; Bohlmann G; Schwieder G
J Cancer Res Clin Oncol; 1988; 114(5):497-501. PubMed ID: 3141427
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of sodium-2-mercaptoethanesulfonate on the gastrointestinal toxicity and lethality of cis-diamminedichloroplatinum.
Allan SG; Smyth JF; Hay FG; Leonard RC; Wolf CR
Cancer Res; 1986 Jul; 46(7):3569-73. PubMed ID: 3085925
[TBL] [Abstract][Full Text] [Related]
4. Mesna does not reduce cisplatin induced nephrotoxicity in the rat.
Millar BC; Siddik ZH; Millar JL; Jinks S
Cancer Chemother Pharmacol; 1985; 15(3):307-9. PubMed ID: 3931929
[TBL] [Abstract][Full Text] [Related]
5. BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.
Boven E; Verschraagen M; Hulscher TM; Erkelens CA; Hausheer FH; Pinedo HM; van der Vijgh WJ
Eur J Cancer; 2002 May; 38(8):1148-56. PubMed ID: 12008205
[TBL] [Abstract][Full Text] [Related]
6. Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats.
Kempf SR; Ivankovic S; Wiessler M; Schmähl D
Br J Cancer; 1985 Dec; 52(6):937-9. PubMed ID: 3935152
[No Abstract] [Full Text] [Related]
7. Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results.
Kempf SR; Ivankovic S
Cancer Treat Rev; 1987 Dec; 14(3-4):365-72. PubMed ID: 3125972
[No Abstract] [Full Text] [Related]
8. Cisplatin combined with tiopronin or sodium thiosulfate: cytotoxicity in vitro and antitumor activity in vivo.
Viale M; Zhang JG; Pastrone I; Mariggiò MA; Esposito M; Lindup WE
Anticancer Drugs; 1999 Apr; 10(4):419-28. PubMed ID: 10378678
[TBL] [Abstract][Full Text] [Related]
9. Studies on hemotoxicity of cyclophosphamide, doxorubicin and cis-diamminodichloroplatinum combined with sodium-2-mercaptoethane sulfonate.
Lerza R; Bogliolo G; Mencoboni M; Saviane A; Pannacciulli I
Tumori; 1988 Jun; 74(3):333-7. PubMed ID: 3135644
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
[TBL] [Abstract][Full Text] [Related]
11. Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle.
Aamdal S; Fodstad O; Kaalhus O; Pihl A
J Natl Cancer Inst; 1984 Sep; 73(3):743-52. PubMed ID: 6590919
[TBL] [Abstract][Full Text] [Related]
12. Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.
Wagner T; Zink M; Schwieder G
J Cancer Res Clin Oncol; 1987; 113(2):160-5. PubMed ID: 3104347
[TBL] [Abstract][Full Text] [Related]
13. Improved therapeutic index of cisplatin by procaine hydrochloride.
Esposito M; Fulco RA; Collecchi P; Zicca A; Cadoni A; Merlo F; Rosso R; Sobrero A
J Natl Cancer Inst; 1990 Apr; 82(8):677-84. PubMed ID: 2319610
[TBL] [Abstract][Full Text] [Related]
14. Cimetidine enhances cisplatin toxicity in mice.
Dorr RT; Soble MJ
J Cancer Res Clin Oncol; 1988; 114(1):1-2. PubMed ID: 3350834
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
Luce JK; Simons JA
Med Pediatr Oncol; 1988; 16(6):372-4. PubMed ID: 3143903
[TBL] [Abstract][Full Text] [Related]
16. Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.
Bernacki RJ; Bansal SK; Gurtoo HL
Cancer Res; 1987 Feb; 47(3):799-802. PubMed ID: 3100025
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
DeWoskin RS; Riviere JE
Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
[TBL] [Abstract][Full Text] [Related]
18. Effect of thymidine on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II).
Grossie VB; Valdivieso M; Drewinko B; Loo TL
Cancer Chemother Pharmacol; 1984; 13(1):27-30. PubMed ID: 6539657
[TBL] [Abstract][Full Text] [Related]
19. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
Iwasaku-Fujimoto M; Fujiwara F; Todo S; Morioka Y; Imashuku S
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836
[TBL] [Abstract][Full Text] [Related]
20. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
Habs MR; Schmähl D
Cancer; 1983 Feb; 51(4):606-9. PubMed ID: 6401591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
